Ketamine Therapy and Psychedelic-Assisted Care: Where It Fits

Mental health care has always evolved in response to what people bring into the room. Some arrive exhausted by years of trial and error with medications that dulled their pain but also their personality. Others carry trauma that refuses to budge, however many times they have told the story. Over the past decade, ketamine therapy and other psychedelic-assisted approaches have become part of that landscape, not as silver bullets, but as tools that can, in the right hands, move stuck systems. The work is not just biochemical. It is medical, psychological, relational, and practical.

What ketamine is, and what it is not

Ketamine is a dissociative anesthetic discovered in the 1960s. At subanesthetic doses, it can rapidly lift depressive symptoms and suicidal thinking. This effect is thought to come from NMDA receptor antagonism that increases glutamate signaling at AMPA receptors, which in turn drives synaptogenesis and neuroplasticity. Many patients feel this as a loosening of rigid patterns, more flexibility, and less catastrophic thinking. That window can open within hours and last days to weeks.

It is not a classic psychedelic like psilocybin or LSD. The experiences overlap at higher doses, with altered perception and a sense of distance from ordinary consciousness, but the pharmacology is different. In the United States, esketamine, a ketamine derivative, is FDA approved for treatment resistant depression and for depressive symptoms in adults with major depression with acute suicidal ideation or behavior. It is delivered as a nasal spray in certified clinics under a REMS program. Intravenous, intramuscular, and lozenge formulations of racemic ketamine are used off label for depression, PTSD, and pain conditions in medical settings.

“Psychedelic-assisted care” is a broader umbrella. It includes structured psychotherapy before, during, and after dosing sessions with agents such as ketamine, and, in research contexts, psilocybin or MDMA. Outside of clinical trials, ketamine is the only widely accessible medicine in this class in the United States that https://www.canyonpassages.com/locations/santa-fe-nm can be paired with psychotherapy today. That availability has driven its use, for better and for worse. As with any tool, the outcomes depend on context, skill, and fit.

Where ketamine fits in the treatment plan

For most people with depression or trauma-related disorders, ketamine is not a first step. Standard treatments work well enough for many, especially when they include good therapy. I start thinking seriously about ketamine therapy in several situations: persistent major depression that has not responded to at least two adequate medication trials, severe depressive episodes with high suicide risk where rapid relief could save a life, and post-traumatic symptoms that have resisted well delivered trauma therapy. Other potential targets, with more variable evidence, include OCD, certain anxiety disorders, and chronic pain with coexisting mood issues.

Most of my patients who respond to ketamine already have a foundation in psychotherapy, often EMDR therapy or another form of trauma therapy. They have language for their distress, strategies to regulate their bodies, and a therapist they trust. Ketamine can then act like a catalyst. It lowers avoidance and shame. It lets them sit with memories or feelings that were intolerable. The work becomes faster and deeper, and sometimes, gentler.

Yet even strong responders need more than medicine. The antidepressant effect of a single ketamine dose peaks within the first 72 hours. Without repeated dosing and integration, relief often fades within one to three weeks. A course of multiple sessions extends benefits, but maintenance will likely be necessary. Personal values, cost, support systems, and medical risk all weigh into the decision.

What a typical course looks like

Ketamine therapy is not one thing. It varies by route, dose, clinic, and philosophy. The most common medical model uses intravenous infusions of racemic ketamine at 0.5 mg per kilogram over about 40 minutes. Some people do better slightly lower or higher, and anesthesiologists will individualize dosing based on response, blood pressure, and side effects. Intramuscular dosing is also common, as are sublingual lozenges used in clinic. Esketamine nasal spray has its own fixed dosing schedule and post-administration monitoring requirements.

A usual series for treatment resistant depression includes six to eight sessions over two to four weeks. Response rates range from roughly 50 to 70 percent in published studies, with remission rates often below half that. PTSD outcomes are promising but less consistent. People who respond often feel lighter, less ruminative, more open to connection, and more able to do the hard parts of therapy. Adverse effects are usually transient, including nausea, dizziness, a rise in blood pressure, and altered perception that settles within one to two hours. A minority experience increased anxiety, dysphoria, or headache.

Integration therapy ties the process together. I meet with patients before the first dose to clarify hopes, worries, and what we will pay attention to during and after sessions. We review anchors they can use if they feel lost, and we outline a plan for structured reflection in the days that follow. I prefer to schedule integration therapy within 24 to 72 hours after each dosing day to leverage the plasticity window. When people are in EMDR therapy, we often use that period for reprocessing, because their defenses are softened and dual attention is easier to maintain.

Here is a focused checklist I use when deciding if someone is ready to start ketamine therapy:

• The diagnosis and target symptoms are clear, and standard treatments have been tried at adequate doses and durations.
• There is a stable psychotherapy relationship in place, or we have lined up integration sessions with a trauma-informed clinician.
• Medical screening shows no uncontrolled hypertension, serious cardiac disease, aneurysm history, active psychosis, or current manic episode.
• Substance use is stable, with supports in place to reduce the risk of ketamine misuse or destabilization.
• The person understands the cost, logistics, and likely need for repeated dosing and ongoing therapy.

Safety, screening, and common drug interactions

Safety starts with medical screening. Ketamine can raise blood pressure and heart rate for a short time. For most healthy adults, this is manageable, but it is dangerous in people with certain vascular conditions or severe, uncontrolled hypertension. A good clinic will measure vitals before, during, and after each dose, and will have emergency protocols and medications on hand.

I avoid ketamine in people with active psychotic disorders or untreated mania. The dissociative effects can worsen those states. I also use caution in people with severe dissociation in the context of complex trauma, not because ketamine is off limits, but because dosing and containment need to be conservative. Pregnancy and breastfeeding are areas with limited safety data. When in doubt, I coordinate closely with obstetrics and consider alternatives.

Medication interactions matter at the margins. Ongoing SSRI or SNRI treatment is generally fine. Benzodiazepines can blunt ketamine’s antidepressant effect at higher doses, so I taper them when possible. Stimulants, particularly amphetamines, can amplify blood pressure spikes. Lamotrigine may reduce the intensity of the dissociative experience and, according to some clinicians, the clinical effect, though data are mixed. MAOIs require extra caution due to hemodynamic risks. Balanced decisions, not rigid rules, serve patients best.

Finally, bladder issues and cognitive side effects are concerns with high frequency, long term recreational ketamine use. In medical settings with careful dosing and spacing, those risks are far lower, but not zero. Headaches, fatigue, and nausea can linger into the next day. No driving or operating machinery on the day of treatment is a standard safety rule.

Set, setting, and the role of psychotherapy

Most people think ketamine therapy is about what happens during the 40 minutes in the chair. In practice, the room does as much as the drug. We dim the lights, choose calming music, remove clocks, and agree on a handful of cues I can offer if anxiety rises. Eye shades help many people turn inward. Others prefer to keep eyes open and focus on breath or a grounding object. I stay present, quiet most of the time, but ready to coach someone through a difficult patch by guiding their attention to the body or the edges of a feeling, not its content.

Psychotherapy wraps around those moments. With EMDR therapy, I rarely do bilateral stimulation during the actual ketamine dosing session. The altered state can make dual attention tricky, and the goal is not to force reprocessing but to let experience surface safely. The sweet spot is often the next day, when access to memory networks is looser, and avoidance is down. People describe a sense that the hard scenes still sting, but they no longer swallow the room. Taps or tones then do their work swiftly, like clearing a logjam after a rain.

For trauma therapy outside of EMDR, ketamine can ease entry into imaginal exposure, memory reconsolidation, or parts work. Someone who has always hit a wall with their inner critic might explore that voice with curiosity rather than contempt. Someone who usually numbs at the first hint of shame might stay with a scene for ten more seconds, then twenty, and stitch together a different ending. Those small expansions add up.

Where couples therapy fits

Not every clinic brings partners into the process, yet relationships often make or break outcomes. I encourage a brief couples therapy session before starting, even if only to align on boundaries, transportation, and aftercare. A partner who understands the likely arc of a dosing day will not panic if their loved one is quiet and abstract for the evening. They will know not to extract meaning prematurely, or to pepper them with questions that turn a tender, pre-verbal state into a debate.

In longer term work, couples therapy helps the pair harvest gains from ketamine therapy. If one person’s mood and reactivity improve, stale patterns can thaw. But change on one side exposes old contracts on the other. A partner accustomed to caretaking might feel unneeded. Resentments that were hidden behind depression can surface. Having a space to name those shifts keeps the system from snapping back to its previous equilibrium. I have seen partners turn the 24 to 72 hour window after dosing into a ritual: a walk with phones off, a simple meal, a practice of sharing one observation each without rebuttal. Small, reliable structures let new neural pathways meet new relational pathways.

PTSD therapy and dissociation: promise with guardrails

The ketamine evidence base for PTSD therapy is still building. Small randomized trials and open label studies suggest meaningful reductions in hyperarousal, reexperiencing, and avoidance, though effects may be less durable than in depression without continued treatment and therapy. In my practice, ketamine is most useful for people who are blocked by fear learning that will not reconsolidate with standard exposure or EMDR alone. It can weaken the felt sense that a memory is dangerous to touch.

There are edge cases. People with complex developmental trauma and high trait dissociation can have paradoxical responses. Rather than feeling safely distanced from pain, they may slip into a familiar, empty fog that mirrors their worst symptoms. Those patients often do better with lower doses, more structure in the room, and a slow build over several sessions. We might anchor in sensation, as simple as the weight of feet on the floor, and keep returning there like a metronome. Once stability is clear, we can widen the window.

Another edge case involves moral injury, common in veterans and first responders who believe they violated core values, or that others did. Ketamine can open a path to grief and self forgiveness that was otherwise closed, but it can also lift defenses too fast. I do not schedule a first session the week of an anniversary date or a high stress event. Timing matters.

A day in the clinic

Patients appreciate specifics. Here is how a ketamine day often unfolds:

• Arrive having had a light meal two to three hours prior, with a ride home arranged, and no pressing commitments after.
• Review vitals and last session notes, confirm intention for the day in a sentence or two. Not a task list, more like a direction: openness, kindness to self, curiosity about a memory.
• Dose is administered while you settle with eye shades and music. For the next 40 to 60 minutes, I monitor vitals, then offer brief guidance if needed. You may feel warmth, time dilation, distance from your usual narrative.
• We spend 15 to 30 minutes debriefing once you are steady. No interpretation, just collecting images, phrases, and body sensations while they are fresh.
• You go home to a quiet, low stimulus setting. Hydrate, avoid alcohol, and jot down anything that returns. An integration session is scheduled within one to three days.

People sometimes expect fireworks. Often the most productive sessions are subtle. A small shift in stance, like turning to face a long avoided hallway in the mind, leads to work in the following days that moves more than any singular vision.

Cost, access, and vetting a clinic

Access shapes care. Esketamine is covered by many insurers, though copays can still be substantial. Off label ketamine clinics typically charge per session. In most cities, infusions run between 400 and 800 dollars each, with package discounts for a full series. Psychotherapy is billed separately. Telehealth ketamine lozenges reduce costs but require careful oversight to be safe and effective. I have seen good outcomes with at home protocols, but only when there is true medical screening, live monitoring during dosing, and a clear integration plan. Mail order lozenges without support are risky.

When choosing a clinic or provider, I suggest asking a few straightforward questions: Who is the prescribing clinician, and will they be present on site? How do they screen for medical and psychiatric contraindications? What monitoring do they provide during dosing? What is their plan if blood pressure spikes or panic escalates? How do they coordinate with my therapist, and do they offer integration support in house if I do not have one? Answers should be concrete, not vague reassurances.

How ketamine pairs with existing therapies

People rarely start ketamine therapy in a vacuum. The work interlaces with what has come before.

With EMDR therapy, ketamine can reduce avoidance and increase access to target memories and core beliefs. Sessions in the days after dosing often move swiftly through phases 3 to 6, with less blocking or looping. I ask patients to bring in images or phrases from the ketamine session as potential targets or resources. A serene landscape, a felt sense of being held, or a line like “I can step aside” can become anchors that buffer more painful material.

In broader trauma therapy, ketamine helps clients shift from narrative to somatic processing. A survivor who knows their story cold but cannot feel safe in a quiet room might, after ketamine, finally notice their breathing change in a way that feels trustworthy. That interoceptive access is a bridge to regulation skills that previously felt like empty techniques.

Couples therapy has a quieter role. It supports the system around the identified patient, reduces misattunements that trigger symptoms, and protects gains by addressing patterns that keep injury alive. Partners can also be coached as allies in exposure work, in ways that do not turn the home into a therapy lab. Sometimes it is as simple as agreeing that after a tough integration session, the evening will be for warmth, not analysis.

Risks, limits, and how to avoid common pitfalls

Ketamine therapy is not a cure, and it is not for everyone. The most common mistake I see is chasing the experience rather than the function. People feel relief and then schedule more sessions reflexively, without anchoring the changes in daily life and relationships. Tolerance creeps in. The sessions feel less meaningful. Bladder irritation or brain fog, rare at first, become more likely with frequent use. A healthy cadence respects both biology and psychology. For many responders, that looks like a front loaded series, then a taper to maintenance sessions every four to eight weeks, coupled with consistent therapy.

Another pitfall is neglecting the basics. Sleep, nutrition, movement, and sunlight modulate the same neuroplastic processes that ketamine taps. Someone who sleeps five fractured hours a night and never leaves a dim apartment will get less durable benefit. So will someone who spends the plasticity window doomscrolling. Simple, boring routines amplify gains.

A final risk is bypass. Ketamine can generate powerful states of unity or detachment. Those experiences can be healing, but they can also seduce people into avoiding conflict, grief, or necessary decisions. I have seen patients come out of a series with less depression but stuck in relationships that harm them, because the expansive feeling mutates into spiritualized passivity. Good therapists name that and realign the work with the person’s values.

Brief portraits from practice

A 45 year old teacher came to me after 15 years of recurrent depression. He had tried four antidepressants and a year of weekly therapy with limited change. We collaborated with a medical clinic on six IV ketamine infusions over three weeks. By the third, his PHQ-9 score had dropped from 20 to 8. The biggest shift was not mood, but flexibility. He could initiate tasks he had avoided for months and stay with discomfort without collapsing into self disgust. We used the days after each dose for EMDR therapy targeting a belief that he was a burden. Gains held with monthly booster infusions for six months. He eventually tapered to two maintenance sessions in the following year while continuing therapy.

A 32 year old paramedic with PTSD and moral injury had tried prolonged exposure and EMDR therapy but hit a wall of shame. We opted for a lower dose ketamine protocol to emphasize safety. After two sessions focused on stabilization and body awareness, she had a third in which she described a powerful sense of being forgiven by the people she could not save. We did not treat that as literal, but as an internal permission to grieve. In the next week’s EMDR session, the most stuck memory finally moved. Nightmares decreased from nightly to once a week over two months. She still had flares on anniversary dates, but now had traction.

A couple in their late thirties came in because one partner’s depression had become the quiet third in their marriage. He pursued ketamine therapy. We framed the process as a joint project. The non-depressed partner learned to ask one open question the evening after dosing and then to let silence do the rest. Over time, the depressed partner’s withdrawal softened, but conflict rose because old patterns no longer fit. Brief couples therapy sessions helped them renegotiate roles. When the ketamine series ended, they had a shared plan for maintenance and clearer boundaries around work hours and family obligations.

The bigger picture of psychedelic-assisted care

Ketamine sits within a larger conversation about substances that induce altered states to catalyze psychotherapy. Psilocybin and MDMA assisted therapies have shown promise in trials for depression and PTSD. As of early 2026, neither is FDA approved for general clinical use in the United States. Regulatory decisions have been cautious, and debates continue about study design, therapist training, and long term safety. This matters because public enthusiasm can outpace evidence, and vulnerable people can be exploited by undertrained providers.

In this environment, careful, patient centered ketamine therapy offers a pragmatic path. It can be delivered safely under medical supervision today. It pairs well with established therapies like EMDR therapy, couples therapy, and other forms of trauma therapy. It demands humility. Some patients will not respond. Some will respond, then relapse. Some will feel worse before they feel better. Clear communication, realistic goals, and steady integration work make the difference.

Deciding if it is worth it for you

If you are considering ketamine therapy, take stock of a few core questions. What have you already tried, at what doses and for how long? What is your support system like, both at home and in care? Are you able to protect time after dosing for rest and integration? Can you afford a full series without creating financial stress that undercuts the benefit? Do your therapist and medical provider communicate openly, and do they agree on a plan? If you can answer yes to most of those, ketamine may be a good fit.

The heart of this work is not the molecule. It is the use of a transient state to practice a different way of relating to pain, memory, and other people. Patients often describe the first session that really helped as a moment of noticing that they could move a half inch to the left inside themselves. It sounds small. It is not. That half inch makes room for choice, and choice is where therapy lives.